TMC announces three specialist service lines to accelerate drug development for biotech and pharma companies
London, UK — 5 November 2025 TMC, a global [...]
London, UK — 5 November 2025 TMC, a global [...]
Breaking into Europe Sweetening launch complexity with an integrated [...]
The European market offers a large patient base, strong [...]
Access is everything for rare disease patients, who often [...]
The line between medical affairs and drug commercialisation functions [...]
The actionable, real-time feedback medical science liaisons (MSL) gather [...]
Small and mid-sized biotechs and pharma companies live and [...]